Circulating Biomarkers for Discrimination between Aseptic Joint Failure, Low-Grade Infection, and High-Grade Septic Failure

Clinical Infectious Diseases

Volumn 61, Issue 3, 2015, Pages 332-341

  Ettinger, Max ^a   Calliess, Tilman ^a   Kielstein, Jan T ^a   Sibai, Jasmin ^a   Brückner, Thomas ^a   Lichtinghagen, Ralf ^b   Windhagen, Henning ^a   Lukasz, Alexander ^a,c  

^a Department of Orthopaedic Surgery ^*  (United States)

^b HANNOVER MEDICAL SCHOOL   (Germany)

^c UNIVERSITY HOSPITAL MÜNSTER   (Germany)

Author keywords

high grade; joint infection; low grade; septic joint failure

Indexed keywords

BIOLOGICAL MARKER; C REACTIVE PROTEIN; INTERLEUKIN 10; INTERLEUKIN 6; LIPOPOLYSACCHARIDE BINDING PROTEIN; PROCALCITONIN; TUMOR NECROSIS FACTOR ALPHA;

ADULT; AREA UNDER THE CURVE; DIAGNOSTIC TEST ACCURACY STUDY; FEMALE; HIGH RISK POPULATION; HIP ARTHROPLASTY; HIP PROSTHESIS; HUMAN; KNEE ARTHROPLASTY; KNEE PROSTHESIS; LEUKOCYTE COUNT; LOW RISK PATIENT; MAJOR CLINICAL STUDY; MALE; NONHUMAN; PERIPROSTHETIC JOINT INFECTION; PREDICTIVE VALUE; PRIORITY JOURNAL; PROSPECTIVE STUDY; PROSTHESIS LOOSENING; RECEIVER OPERATING CHARACTERISTIC; REVIEW; SHOULDER ARTHROPLASTY; SHOULDER PROSTHESIS; ADVERSE EFFECTS; AGED; BLOOD; MIDDLE AGED; PROSTHESIS FAILURE; PROSTHESIS-RELATED INFECTIONS; SEPSIS;

AGED; BIOMARKERS; FEMALE; HIP PROSTHESIS; HUMANS; KNEE PROSTHESIS; MALE; MIDDLE AGED; PROSPECTIVE STUDIES; PROSTHESIS FAILURE; PROSTHESIS-RELATED INFECTIONS; ROC CURVE; SEPSIS;

EID: 84938565756     PISSN: 10584838     EISSN: 15376591     Source Type: Journal    
DOI: 10.1093/cid/civ286     Document Type: Review

References (29)

1. Kurtz SM, Lau E, Ong K, Zhao K, Kelly M, Bozic KJ. Future young patient demand for primary and revision joint replacement: national projections from 2010 to 2030. Clin Orthop Relat Res 2009; 467: 2606-12.
2. Kurtz S, Ong K, Lau E, Mowat F, Halpern M. Projections of primary and revision hip and knee arthroplasty in the United States from 2005 to 2030. J Bone Joint Surg Am 2007; 89:780-5.
3. Del Pozo JL, Patel R. Clinical practice. Infection associated with prosthetic joints. N Engl J Med 2009; 361:787-94.
4. Tsukayama DT, Estrada R, Gustilo RB. Infection after total hip arthroplasty. A study of the treatment of one hundred and six infections. J Bone Joint Surg Am 1996; 78:512-23.
5. Trampuz A, Piper KE, Jacobson MJ, et al. Sonication of removed hip and knee prostheses for diagnosis of infection. N Engl J Med 2007; 357:654-63.
6. Morawietz L, Tiddens O, Mueller M, et al. Twenty-three neutrophil granulocytes in 10 high-power fields is the best histopathological threshold to differentiate between aseptic and septic endoprosthesis loosening. Histopathology 2009; 54:847-53.
7. Morawietz L, Classen RA, Schroder JH, et al. Proposal for a histopathological consensus classification of the periprosthetic interface membrane. J Clin Pathol 2006; 59:591-7.
8. Trampuz A, Osmon DR, Hanssen AD, Steckelberg JM, Patel R. Molecular and antibiofilm approaches to prosthetic joint infection. Clin Orthop Relat Res 2003; 69-88.
9. Spangehl MJ, Masterson E, Masri BA, O'Connell JX, Duncan CP. The role of intraoperative gram stain in the diagnosis of infection during revision total hip arthroplasty. J Arthroplasty 1999; 14:952-6.
10. Shih LY,Wu JJ, Yang DJ. Erythrocyte sedimentation rate and C-reactive protein values in patients with total hip arthroplasty. Clin Orthop Relat Res 1987; 238-46.
11. Piper KE, Fernandez-Sampedro M, Steckelberg KE, et al. C-reactive protein, erythrocyte sedimentation rate and orthopedic implant infection. PloS One 2010; 5:e9358.
12. Osmon DR, Berbari EF, Berendt AR, et al. Diagnosis and management of prosthetic joint infection: clinical practice guidelines by the Infectious Diseases Society of America. Clin Infect Dis 2013; 56:e1-25.
13. Biomarkers Definitions Working G. Biomarkers and surrogate endpoints: preferred definitions and conceptual framework. Clin Pharmacol Ther 2001; 69:89-95.
14. Allin KH, Nordestgaard BG. Elevated C-reactive protein in the diagnosis, prognosis, and cause of cancer. Crit Rev Clin Lab Sci 2011; 48: 155-70.
15. Kurosaka D, Hirai K, Nishioka M, et al. Clinical significance of serum levels of vascular endothelial growth factor, angiopoietin-1, and angiopoietin-2 in patients with rheumatoid arthritis. J Rheumatol 2010; 37:1121-8.
16. Michalska-Jakubus M, Kowal-Bielecka O, Chodorowska G, Bielecki M, Krasowska D. Angiopoietins-1 and-2 are differentially expressed in the sera of patients with systemic sclerosis: high angiopoietin-2 levels are associated with greater severity and higher activity of the disease. Rheumatology 2011; 50:746-55.
17. Graham SM, Mwilu R, Liles WC. Clinical utility of biomarkers of endothelial activation and coagulation for prognosis in HIV infection: a systematic review. Virulence 2013; 4:564-71.
18. Parvizi J, Zmistowski B, Berbari EF, et al. New definition for periprosthetic joint infection: from theWorkgroup of the Musculoskeletal Infection Society. Clin Orthop Relat Res 2011; 469:2992-4.
19. Fehring TK, McAlister JA Jr. Frozen histologic section as a guide to sepsis in revision joint arthroplasty. Clin Orthop Relat Res 1994; 229-37.
20. Pandey R, Berendt AR, Athanasou NA. Histological and microbiological findings in non-infected and infected revision arthroplasty tissues. The OSIRIS Collaborative Study Group. Oxford Skeletal Infection Research and Intervention Service. Arch Orthop Trauma Surg 2000; 120: 570-4.
21. Moran E, Byren I, Atkins BL. The diagnosis and management of prosthetic joint infections. J Antimicrob Chemother 2010; 65(suppl 3): iii45-54.
22. Zimmerli W, Trampuz A, Ochsner PE. Prosthetic-joint infections. N Engl J Med 2004; 351:1645-54.
23. Randau TM, Friedrich MJ, Wimmer MD, et al. Interleukin-6 in serum and in synovial fluid enhances the differentiation between periprosthetic joint infection and aseptic loosening. PloS One 2014; 9:e89045.
24. Elgeidi A, Elganainy AE, Abou Elkhier N, Rakha S. Interleukin-6 and other inflammatory markers in diagnosis of periprosthetic joint infection. Int Orthop 2014; 38:2591-5.
25. Buttaro MA, Tanoira I, Comba F, Piccaluga F. Combining C-reactive protein and interleukin-6 may be useful to detect periprosthetic hip infection. Clin Orthop Relat Res 2010; 468:3263-7.
26. Chen A, Fei J, Deirmegian C. Diagnosis of periprosthetic infection: novel developments. J Knee Surg 2014; 27:259-65.
27. Glehr M, Friesenbichler J, Hofmann G, et al. Novel biomarkers to detect infection in revision hip and knee arthroplasties. Clin Orthop Relat Res 2013; 471:2621-8.
28. Friedrich MJ, Randau TM, Wimmer MD, et al. Lipopolysaccharidebinding protein: A valuable biomarker in the differentiation between periprosthetic joint infection and aseptic loosening? Int Orthop 2014; 38:2201-7.
29. Bottner F, Wegner A, Winkelmann W, Becker K, Erren M, Gotze C. Interleukin-6, procalcitonin and TNF-alpha: markers of peri-prosthetic infection following total joint replacement. J Bone Joint Surg Br 2007; 89:94-9.